Remove Cannabinoids Remove Clinical Trials Remove eCommerce
article thumbnail

cbdMD Therapeutics Releases Research Plan

Cannabis Law Report

Seeks To Identify Novel Cannabinoids For Therapeutic Use. Following the execution of this work, cbdMD Therapeutics will perform the requisite toxicological studies with Ion Tox, a leading in vitro toxicology and ADME-PK testing company, to support the safety of the cannabinoids of interest. CHARLOTTE, N.C.–(BUSINESS cbdMD, Inc.

article thumbnail

The Valens Company Achieves Access to GMP Manufacturing in Australia & Expands International Footprint to Asia-Pacific through Exclusive Partnership with Epsilon Healthcare

Cannabis Law Report

Epsilon also owns a number of medicinal cannabis assets, including the Tetra Health clinic, and the Medimar Platform – an end-to-end ecommerce solution for nutraceuticals and cannabis. The facility consists of its own QC lab and grade D cleanroom space for the manufacture of oral dose format products. Schedule 1.

Access 97